
Sareum Holdings Investor Relations Material
Latest events

H1 2025
Sareum Holdings
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Sareum Holdings plc
Access all reports
Sareum Holdings plc is a UK-based biotechnology company focused on the discovery and development of small molecule therapeutics targeting cancer and autoimmune diseases. The company specializes in kinase inhibition and advances its drug candidates through preclinical and early clinical development stages. Sareum’s lead programs target immune and inflammation pathways, and the company collaborates with partners to support further development and commercialization. Sareum Holdings plc is headquartered in Cambridge, United Kingdom, and its shares are listed on the AIM.
Key slides for Sareum Holdings plc


H2 2024
Sareum Holdings plc


H1 2025
Sareum Holdings plc
Latest articles
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
Ticker symbol
SAR
Country
🇬🇧 United Kingdom